Literature DB >> 6326789

Myasthenia gravis and atracurium. A case report.

A M Macdonald, R I Keen, N D Pugh.   

Abstract

The degree, duration of and recovery from neuromuscular blockade induced by atracurium in a patient with myasthenia gravis were monitored and recorded using the evoked compound muscle action potentials (EMG). The anaesthetic and perioperative management were simplified by the use of this technique. The significance of the behaviour of atracurium is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326789     DOI: 10.1093/bja/56.6.651

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

1.  Anaesthesia for trans-sternal thymectomy in myasthenia gravis.

Authors:  N Redfern; P J McQuillan; I D Conacher; D T Pearson
Journal:  Ann R Coll Surg Engl       Date:  1987-11       Impact factor: 1.891

Review 2.  Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes.

Authors:  Charlotte Vrinten; Angeli M van der Zwaag; Stephanie S Weinreich; Rob J P M Scholten; Jan J G M Verschuuren
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

Review 3.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

4.  Clinical use of atracurium in myasthenia gravis: a case report.

Authors:  F M Ramsey; G D Smith
Journal:  Can Anaesth Soc J       Date:  1985-11

5.  Cumulative dose-response curves for atracurium in patients with myasthenia gravis.

Authors:  C E Smith; F Donati; D R Bevan
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

6.  Ephedrine as add-on therapy for patients with myasthenia gravis: protocol for a series of randomised, placebo-controlled n-of-1 trials.

Authors:  Charlotte Vrinten; Alexander F Lipka; Erik W van Zwet; Kirsten J M Schimmel; Martina C Cornel; Marja R Kuijpers; Yechiel A Hekster; Stephanie S Weinreich; Jan J G M Verschuuren
Journal:  BMJ Open       Date:  2015-07-16       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.